ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

ACS Forms Foundation To Handle Large Gifts

September 4, 1992